Company / PP&E (Net)
Illumina, Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$759.0M
FY2025
5-year range
$759.0M / $1.1B
FY2021-FY2025
Trend
-6.9%
vs FY2024
Sector context
#38 of 130
Health Care
What the data says
At $759M, Illumina, Inc.'s pp&e (net) ranks #38 of 130 in the Health Care sector. PP&E (Net) has declined for 3 consecutive years, from $1.1B in FY2022 to $759M in FY2025.
Based on SEC 10-K filings.
$759M in FY2025 with a 5-year CAGR of -3.8%.
Declined from $1.0B to $759M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -11.4%
- 5-Year CAGR
- -3.8%
- 10-Year CAGR
- -
Sector benchmark
#38 of 130 in Health CareTop 29% of 130This company $759.0M Sector average $1.3B
▼
-43.5% below sector average
Key checks
Key Insights
- Illumina, Inc.'s pp&e (net) has declined for 3 consecutive years.
- 5-year CAGR of -3.8%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 6.9% year-over-year.
- Ranks #38 out of 130 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $759.0M | -6.9% |
| FY2024 | $815.0M | -19.1% |
| FY2023 | $1.0B | -7.7% |
| FY2022 | $1.1B | +6.5% |
| FY2021 | $1.0B | +11.1% |
| FY2020 | $922.0M | -14.2% |
| FY2019 | $1.1B | +0.0% |
| FY2018 | $1.1B | +15.5% |
| FY2017 | $931.0M | +30.6% |
| FY2016 | $713.0M | +108.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026